Jilin Xidian Pharmaceutical Technology Development Co., Ltd. announces progress on its share repurchase plan. As of March 5, 2026, the company has repurchased 765,000 shares, representing 1.0001% of its total share capital, for approximately RMB 23.5 million. The repurchase is within the approved price range and duration.
Summary generated by AI · Always verify with source document
Securities Code: 301130 Securities Abbreviation: Xidian Pharmaceutical Announcement Number: 2026-014
Jilin Xidian Pharmaceutical Technology Development Co., Ltd. Announcement on Progress of Share Repurchase Proportion Reaching 1%
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.